Walmart agrees to $3.1 billion opioid settlement framework
BOISE, Idaho (KIFI) - Walmart agreed to the framework of a $3.1 billion settlement, which resolves allegations from multiple states’ attorneys general that the company failed to regulate opioid prescriptions contributing to the nationwide opioid crisis.
Attorney General Lawrence Wasden announced Tuesday the settlement will provide more than $3 billion nationally and will require significant improvements in how Walmart's pharmacies handle opioids.
State attorneys general on the executive committee, attorneys representing local governments, and Walmart have agreed to this settlement, and it is now being sent to other states for review and approval.
The settlement will include:
- $3.1 billion to be divided by states that sign on, local governments, and tribes, which must be used to provide treatment and recovery services to people struggling with opioid use disorder.
- Broad, court-ordered requirements, including oversight to prevent fraudulent prescriptions and flag suspicious prescriptions.
The parties are optimistic that the settlement will gain support of the required 43 states by the end of 2022, allowing local governments to join the deal during the first quarter of 2023. Further details about how the money will be distributed will be forthcoming. Last month, states confirmed that promising negotiations were also underway with Walgreens and CVS. The parties continue their efforts to achieve those agreements.
